Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel in Refractory Status Epilepticus
NCT05684978Phase 4Terminated
- Sponsor
- Wayne State University
- Start
- Oct 2025
- Primary completion
- Oct 2025
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of perampanel in status epilepticus (SE), sponsored by Wayne State University. Primary endpoint: Successful wean of IV anesthetics without recurrence of status epilepticus at 48 hours. Started Oct 2025; status: terminated.
02
Drugs
perampanel
03
Conditions
status epilepticus (SE)
Beyond the preview
Go deeper on NCT05684978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05684978.